Trial of an RNActive®-Derived Cancer Vaccine in Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by CureVac GmbH.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
CureVac GmbH
Information provided by:
CureVac GmbH
ClinicalTrials.gov Identifier:
NCT00923312
First received: June 16, 2009
Last updated: March 4, 2011
Last verified: March 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | February 2012 |
| Estimated Primary Completion Date: | October 2010 (Final data collection date for primary outcome measure) |
No publications provided by CureVac GmbH
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):